Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Resnick

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Medical Hypotheses|October 6, 2000
Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistulaS Wattanasirichaigoon, F D Gordon, R H Resnick
The New England Journal of Medicine|February 11, 1982
A prospective trial of D-penicillamine in primary biliary cirrhosisD S Matloff, E Alpert, R H Resnick, et al.
Digestive Diseases and Sciences|February 1, 1990
Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPAR H Resnick, H Royal, W Marshall, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1970
Renal function and fecal flora after colon bypassR H Resnick, T C Chalmers, G P Chatterjee, et al.
Digestion|January 1, 1974
Preliminary observations of d-penicillamine therapy in acute alcoholic liver diseaseR H Resnick, J Boitnott, F L Iber, et al.
The American Journal of Gastroenterology|December 1, 1973
Urinary hydroxyproline excretion in hepatic disordersR H Resnick, J C Cerda, J Boitnott, et al.
Gastroenterology|January 1, 1978
Cirrhotic portal hypertension: morbidity of continued alcoholismN V Pande, R H Resnick, W Yee, et al.
The American Journal of Gastroenterology|April 1, 1978
A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patientsJ B Shumaker, R H Resnick, J T Galambos, et al.
Gastroenterology|November 1, 1974
A controlled study of the therapeutic portacaval shuntR H Resnick, F L Iber, A M Ishihara, et al.
Gastroenterology|February 1, 1977
Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosisJ L Shurberg, R H Resnick, R S Koff, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|October 6, 2000
Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistulaS Wattanasirichaigoon, F D Gordon, R H Resnick
The New England Journal of Medicine|February 11, 1982
A prospective trial of D-penicillamine in primary biliary cirrhosisD S Matloff, E Alpert, R H Resnick, et al.
Digestive Diseases and Sciences|February 1, 1990
Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPAR H Resnick, H Royal, W Marshall, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 1, 1970
Renal function and fecal flora after colon bypassR H Resnick, T C Chalmers, G P Chatterjee, et al.
Digestion|January 1, 1974
Preliminary observations of d-penicillamine therapy in acute alcoholic liver diseaseR H Resnick, J Boitnott, F L Iber, et al.
The American Journal of Gastroenterology|December 1, 1973
Urinary hydroxyproline excretion in hepatic disordersR H Resnick, J C Cerda, J Boitnott, et al.
Gastroenterology|January 1, 1978
Cirrhotic portal hypertension: morbidity of continued alcoholismN V Pande, R H Resnick, W Yee, et al.
The American Journal of Gastroenterology|April 1, 1978
A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patientsJ B Shumaker, R H Resnick, J T Galambos, et al.
Gastroenterology|November 1, 1974
A controlled study of the therapeutic portacaval shuntR H Resnick, F L Iber, A M Ishihara, et al.
Gastroenterology|February 1, 1977
Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosisJ L Shurberg, R H Resnick, R S Koff, et al.
Pageof 4